1Sica A, Schioppa T, Mantovani A, et al. Turnout-associated macrophages are a distinctM2 polarised population promoting tumour progression: potential targets of anti-cancer therapy [J]. Cancer, 2006, 42 (6):717-727.
2Martinez FO, Sica A, Mantovani A, et al. Macrophage activation and polarization [J].Front Biosci,2008,13:453-461.
4Mantovani A, Sozzani S, Locati M, et al. Infiltration of tumour sbymacrophages and dendritic cells: tumour-associated ma- crophages as a paradigm for polarized M2 mononuclear phagocytes [J]. Novartis Found Syrup,2004,256(l l ): 137-145.
5Hagemann T, Wilson J, Burke F, et al, Ovarian cancer cell spolarizemacrophages toward a tumor-associated phenotype [J]. Immunol, 2006,176(8):5023-5032.
6Knowles H, Leek IL Harris AL, Macrop hage infiltration and angiogenesis in human malignancy [J]. Novartis Found Syrup, 2004, 256: 189-200.
7Chen JJ, Lin YC, Yao PL, et al. Tumor-associated macrophages: the double edged sword in cancer progression [J]. Clin Oncol, 2005, 23 (5) : 953-964.
8Christina HS, Stacey DCB, Praveen RA, et al. Breast cancer cells induce stromalfibroblasts to express MMP-9 via secretion of TNF-ct and TGF-13[J].Cell Sci,2005, 118 (4):2143-2153.
9Klimp AH, Hollema H, Kemp inga C, el al. Expression of cyclooxyge-Nase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated ma crophages[J]. Cancer Res, 2001, 61 (19): 7305-7309.
10Claire El, Jeffrey WE Distinct role ofmacrophages in different tumor microenvi ronments[J].Cancer Res,2006,66 (2): 605-612.
2Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Fit4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases [J].EMBO J. 1996. 15(7): 1751-1757.
3Akagi K, Ikeda Y, Miyazaki M, et al. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectalcancer tissues[J]. Br J Cancer, 2000, 83(7): 887-891.
4Schoppmann SF, Schindl M, Breiteneder-Geleff S, et al.Inflammatory stromal reaction correlates with lymphatic microvessel density in early-stage cervival cancer [J]. Anticancer Res, 2001,21(5): 3419-3423.
5Skobe M, Hamberg LM, Hawighorst T, et al. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma [J]. Am J Pathol, 2001, 159(3): 893-903.
6Collingridge DR, Hill SA, Chaplin DJ. Proportion of infiltrating IgG-binding immune cells predict for tumour hypoxia [J]. Br JCancer, 2001, 84 (5): 626-630.
7Ono M,Tofisu H,Fukushi J,et al.Biological implications of macrophage infiltration in human tumor angiogenesis[J].Cancer Chemother Pharmacol,1999,43:S69—71.
8Leek RD, Lewis CE, Whitehouse R, et al. Association of macrophage infiltration with angiogenesis and prognosis ininvasive breast carcinoma [J]. Cancer Res, 1996,56(20): 4625-4629.
9Schoppmann SF, Birner P, Stockl J, et al. Tumor-associated macrophages express Lymphatic endothelial growth factors and are related to peritumoral ly mphangiogenesis [J]. Am J Pathol, 2002,161(3): 947-956.
10Jaime R,Fiona GC,Andrew LW.A rat model of pancreatic ductal adenocarcinoma:Targeting chemical carcinogens.Surgery,1997,122:82-90.
7Condeelis J,Pollard JW.Macrophages:obligate partners for tumor cell migration,invasion and metastasis[J].Cell,2006,124(2):263-266.
8Zhang BC,Gao J,Wang J,et al.Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma[J].Med Oncol,2010,30(7):11-15.
